JP Morgan Chase’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Other funds holding LENZ
7IH
JP Morgan Chase's LENZ Position: Q3 2026 in Review
JP Morgan Chase increased its LENZ Therapeutics (LENZ) stake by 6.6% in Q3 2026, buying an estimated $3.96K and bringing the position to 12,776 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6570.
JP Morgan Chase first reported a position in LENZ in Q3 2021 and has held it in 21 quarters since. The position peaked at $523K in Q3 2025. 138 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.
- JP Morgan Chase held 12,776 shares of LENZ Therapeutics worth $49.3K as of Q3 2026.
- JP Morgan Chase bought 795 LENZ Therapeutics shares in Q3 2026, an estimated $3.96K.
- LENZ Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #6570 holding.
- JP Morgan Chase first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 21 quarters since.
- JP Morgan Chase's LENZ Therapeutics position peaked at $523K in Q3 2025.
- 138 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.